BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4205522)

  • 1. A serum component related to nonimmunoglobulin amyloid protein AS, a possible precursor of the fibrils.
    Husby G; Natvig JB
    J Clin Invest; 1974 Apr; 53(4):1054-61. PubMed ID: 4205522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloidosis in rheumatoid arthritis.
    Husby G
    Ann Clin Res; 1975 Jun; 7(3):154-67. PubMed ID: 1103711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased circulating serum amyloid A protein derivatives in rheumatoid arthritis patients with secondary amyloidosis.
    Migita K; Eguchi K; Tsukada T; Kawabe Y; Takashima H; Mine M; Aoyagi T; Ichinose Y; Nagataki S
    Lab Invest; 1996 Sep; 75(3):371-5. PubMed ID: 8804360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of amyloid related protein SAA complexed with serum lipoproteins (apoSAA).
    Marhaug G; Sletten K; Husby G
    Clin Exp Immunol; 1982 Nov; 50(2):382-9. PubMed ID: 7151331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel amyloid fibril protein isolated from senescence-accelerated mice.
    Matsumura A; Higuchi K; Shimizu K; Hosokawa M; Hashimoto K; Yasuhira K; Takeda T
    Lab Invest; 1982 Sep; 47(3):270-5. PubMed ID: 6810021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the amyloid A protein (AA protein) and a related serum component-purification-partial characterization and tissue origin and distribution in different types of amyloidosis.
    Franklin EC; Rosenthal CJ; Pras M
    Adv Nephrol Necker Hosp; 1975; 5():89-97. PubMed ID: 811096
    [No Abstract]   [Full Text] [Related]  

  • 7. Isolation of a low-molecular-weight serum component antigenically related to an amyloid fibril protein of unknown origin.
    Linke RP; Sipe JD; Pollock PS; Ignaczak TF; Glenner GG
    Proc Natl Acad Sci U S A; 1975 Apr; 72(4):1473-6. PubMed ID: 805429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "A" protein of amyloidosis. Isolation of a cross-reacting component from serum by affinity chromatography.
    Benson MD; Skinner M; Lian J; Cohen AS
    Arthritis Rheum; 1975; 18(4):315-22. PubMed ID: 50844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum amyloid P-component levels in amyloidosis, connective tissue diseases, infection, and malignancy as compared to normal serum.
    Skinner M; Vaitukaitis JL; Cohen AS; Benson MD
    J Lab Clin Med; 1979 Oct; 94(4):633-8. PubMed ID: 479670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis, diagnosis and treatment of systemic amyloidosis.
    Pepys MB
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):203-10; discussion 210-1. PubMed ID: 11260801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-associated changes of an amyloid related serum component.
    Rosenthal CJ; Franklin EC
    Trans Assoc Am Physicians; 1974; 87():159-68. PubMed ID: 4456729
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative studies of the high molecular weight amyloid fibril proteins and similar components from normal tissues.
    Scott DL; Marhaug G; Husby G
    Clin Exp Immunol; 1983 Jun; 52(3):693-701. PubMed ID: 6409474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis.
    Pepys MB; Herbert J; Hutchinson WL; Tennent GA; Lachmann HJ; Gallimore JR; Lovat LB; Bartfai T; Alanine A; Hertel C; Hoffmann T; Jakob-Roetne R; Norcross RD; Kemp JA; Yamamura K; Suzuki M; Taylor GW; Murray S; Thompson D; Purvis A; Kolstoe S; Wood SP; Hawkins PN
    Nature; 2002 May; 417(6886):254-9. PubMed ID: 12015594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know].
    Arbustini E; Gavazzi A; Merlini G
    Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic studies of the major nonimmunoglobulin protein of amyloid. I. Identification and partial characterization of a related serum component.
    Levin M; Pras M; Franklin EC
    J Exp Med; 1973 Aug; 138(2):373-80. PubMed ID: 4198200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of a serum protein, C1t, to a common nonfibrillar constituent of amyloid (P component) as revealed by immunohistochemical studies.
    Katz A; Weicker-Thorne J; Painter RH
    Am J Pathol; 1977 Sep; 88(3):679-98. PubMed ID: 329683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Amyloidosis. I. Recent findings concerning amyloid substance].
    Lovisetto P; Gilardi E; Frascisco M; Marchi L; Mairano D
    Minerva Med; 1980 Jun; 71(25):1793-800. PubMed ID: 6997780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New, third class of amyloid fibril protein.
    Husby G; Natvig JB; Sletten K
    J Exp Med; 1974 Mar; 139(3):773-8. PubMed ID: 4204730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid A in systemic amyloidosis associated with cancer.
    Husby G; Marhaug G; Sletten K
    Cancer Res; 1982 Apr; 42(4):1600-3. PubMed ID: 7060030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal amyloidosis in childhood. An overview of the topic with 25 years experience.
    Tinaztepe K
    Turk J Pediatr; 1995; 37(4):357-73. PubMed ID: 8560604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.